Back to search

Article

Predictors of Efficacy of Anamorelin in Non-small-cell Lung Cancer Patientswith Cachexia: A Retrospective Study

2023-06-13

Abstract excerpt

PURPOSE Anamorelin, a ghrelin receptor agonist, has recently been approved in Japan for the treatment of cachexia in patients with lung and gastrointestinal cancer. However, only a few studies have investigated whether anamorelin is actually useful in clinical settings. We therefore investigated its efficacy in terms of patient characteristics. METHODS We retrospectively evaluated 40 patients with non-small-cell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d37c5d9-35a1-5d65-83b4-5f3afcbb7f7e
DOI
10.21203/rs.3.rs-3032275/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predictors of Efficacy of Anamorelin in Non-small-cell Lung Cancer Patientswith Cachexia: A Retrospective StudyDOI 10.21203/rs.3.rs-3032275/v1
Select a neighboring publication to make it the new centre.